Blastomycosis laboratory findings

Jump to navigation Jump to search

Blastomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blastomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blastomycosis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blastomycosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Blastomycosis laboratory findings

CDC on Blastomycosis laboratory findings

Blastomycosis laboratory findings in the news

Blogs on Blastomycosis laboratory findings

Directions to Hospitals Treating Blastomycosis

Risk calculators and risk factors for Blastomycosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]


Overview

Once suspected, the diagnosis of blastomycosis can usually be confirmed by demonstration of the characteristic broad based budding organisms in sputum or tissues by KOH prep, cytology, or histology.

Laboratory Findings

Commonly performed tests include:

  • Culture of the organism remains the definitive diagnostic standard, but due to slow growing nature can lead to delay in treatment up to several weeks.
  • Culture on dextrose sabourd agar at 37ºC can be used for diagnosis. Highest diagnostic yield is of bronchoscopy derived fluid, followed by sputum. Real time PCR is being experimentally tested for direct diagnosis from culture or tissue. [1]
  • KOH preparation - shows a broad based budding yeast as shown in the microscopic picture above. sputum, blood, pleural and other body fluids may be used, however this process has a low clinical yield.
  • Tissue biopsy of skin or other organs may be required in order to diagnose extra-pulmonary disease. A granulomatous inflammation might be suggestive of fungal presence but is not diagnostic.
  • Commercially available urine antigen testing appears to be quite sensitive in suggesting the diagnosis in cases where the organism is not readily detected. It appears to be more helpful than serum antigen testing.
  • Serological testing is limited in utility by the fact that there is a considerable overlap with other fungal antigens.

However, sometimes blood and sputum cultures may not detect blastomycosis; lung biopsy is another option, and results will be shown promptly.

Gallery

References

  1. Sidamonidze, K.; Peck, MK.; Perez, M.; Baumgardner, D.; Smith, G.; Chaturvedi, V.; Chaturvedi, S. (2012). "Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue". J Clin Microbiol. 50 (5): 1783–6. doi:10.1128/JCM.00310-12. PMID 22403418. Unknown parameter |month= ignored (help)
  2. 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 "Public Health Image Library (PHIL)".

Template:WS